Figure 7.
The effects of p38 MAP kinase inhibition with SB 203580 (7A) and NOS inhibition with nitro L-arginine (N-LA; 7B) on GLP-1 mediated myocardial glucose uptake in Control (n=6) and DCM (n=6).
*p<0.02 GLP-1 compared to Blockade +GLP-1
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.